Two- and three-dimensional rings in drugs.
Using small, flat aromatic rings as components of fragments or molecules is a common practice in fragment-based drug discovery and lead optimization. With an increasing focus on the exploration of novel biological and chemical space, and their improved synthetic accessibility, 3D fragments are attracting increasing interest. This study presents a detailed analysis of 3D and 2D ring fragments in marketed drugs. Several measures of properties were used, such as the type of ring assemblies and molecular shapes. The study also took into account the relationship between protein classes targeted by each ring fragment, providing target-specific information. The analysis shows the high structural and shape diversity of 3D ring systems and their importance in bioactive compounds. Major differences in 2D and 3D fragments are apparent in ligands that bind to the major drug targets such as GPCRs, ion channels, and enzymes.
Wolfson Institute for Biomedical Research, University College London, Gower Street, London, WC1E 6BT, UK.
Matteo
M
Aldeghi
Shipra
S
Malhotra
David L
DL
Selwood
Ah Wing Edith
AW
Chan
D055808:Drug Discovery; D006571:Heterocyclic Compounds / Q000737:chemistry; D019469:Indinavir / Q000737:chemistry; D008024:Ligands; D015394:Molecular Structure
D006571:Heterocyclic Compounds; D008024:Ligands; D019469:Indinavir
drug; fragment; lead optimization; ring